Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Oncternal Therapeutics, Inc./ EFFECT

SEC Filing · EFFECT

Oncternal Therapeutics, Inc.

SEC Filing

Filed Mar 31, 2025Accepted Mar 31, 2025, 8:15 PM EDTCIK 1260990Accession 9999999995-25-000848
View company →Permanent SEC source ↗
Share

Recent company filings

  1. EFFECT filingMar 31, 2025
  2. EFFECT filingMar 31, 2025
  3. EFFECT filingMar 31, 2025
  4. EFFECT filingMar 31, 2025
  5. EFFECT filingMar 31, 2025

As-filed source

Primary evidence
As filedOpen full document ↗